CClinicalTrials.gg
Enrolling by invitationNCT06914804Updated Apr 6, 2025

Stomasense: A New Route to the Proactive Detection and Management of Leaks Within Ostomy Pouches

An interventional study of Stomasense in Ileostomy - Stoma, sponsored by University of Ulster. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by University of Ulster · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jan 2026, 8 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

People living with an ileostomy may often experience leaks from their stoma pouches. Leakages are a highly stressful experience, so it is no surprise that worry about leaks is very common among ileostomates and this can contribute to increased anxiety and impact negatively on quality of life. Ileostomates will make changes to their lifestyle to minimise the occurrence of leaks; they may avoid travelling long distances, steer clear of busy social events and often restrict certain food(s) and / or drink(s). The latter stands in the way of achieving a healthy balanced diet and can put ileostomates at risk of developing nutritional deficiencies.

Researchers at ulster university have developed a leak sensor device which can be worn unobtrusively alongside any stoma pouch. The device can detect the early stages of a leak from the stoma bag and alerts the user, meaning they are able to change their pouch before it's too late. Participants will be asked to trial 2 versions of the device, each over a 2-week period. At the beginning and end of each period participants will complete a series of questionnaires to allow the research team to determine device efficacy and impact on quality of life. Food diaries will also be completed by participants to give an indication of how dietary intake can impact the incidence of pouch leakage.

Read the detailed description

Surgical diversion of the bowel to create an opening in the abdomen (stoma) is a common procedure in the treatment of various gastrointestinal conditions; 21 000 stomas are created in the UK each year and it is estimated that 176 000 - 205 000 individuals in the UK are living with a stoma. This is a life-changing operation which requires significant physical and psychological adaptation particularly as bowel/bladder content is collected in a disposable pouch that adheres to the abdomen. Leakage, especially in public, is a constant worry resulting in decreased social interactions, increased anxiety and depression and can have a tremendous impact on family and work life. The extent of the problem was confirmed by the Ostomy Life Study (2015) which surveyed some 4000 ostomates from 11 different countries and found the majority (91%) of participants reported that leakage of the pouch was a concern with 69% confirming that it was their prime worry and greatly impacted on their quality of life (QoL). Leakage events are very traumatic emotionally and will impact an individual's practical management of their ostomy; stoma effluent in contact with the epidermal layer is a major contributing factor in the development of peristomal skin complications (PCS), this in turn can cause difficulty in adhesion of the baseplate to the affected skin, therefore further contributing to the future leaks.

To put an end to this cycle of worsening skin integrity and subsequent increased frequency of leaks, new leak sensor technology has been developed by Ulster University which can be used with any stoma pouch system to detect the early onset of stoma pouch failure - providing an alert that allows the patient to replace the pouch before catastrophic seepage of bowel/bladder content.

Whilst this new leak sensor technology will be extremely useful in the early detection of leaks, it is important to also consider how an individual's management of their stoma, as well as health and lifestyle behaviours, could be manipulated to further reduce the incidence of leaks and improve QoL. In a previous study, participants identified food consumption (i.e., eating certain foods) as being the most prominent contributor to the incidence of leaks. It has been reported that fruit and vegetables are avoided by ostomates - in particular those with an ileostomy - to help minimise the risk of leaks. Obviously, this is less than ideal, considering the well-established health benefits of consuming a diet rich in fruit and vegetables. At present, there is no evidence confirming the efficacy of restricting dietary intake to reduce the frequency of leaks. Therefore, it is possible that people living with a stoma are unnecessarily restricting their dietary intake and putting themselves at risk of various nutrient deficiencies and associated health conditions.

The over-riding aim of the current proposal is to validate a smart device that can be worn unobtrusively alongside existing stoma pouch systems whilst monitoring the condition of the adhesive skin wafer, such that erosion of the bond can be detected before a leak occurs. This would enable the wearer to replace the pouch avoiding the consequences of leakage and accompanying distress, therefore improving QoL and psychological well-being. The impact of the device on participant well-being will be assessed using a series of validated questionnaires. The sensor is not a medical device as it only interacts with the stoma bag and flange and does not interact directly with the participant or their bodily fluids.

The sensing device will:

  1. Accurately detect the onset of leaks.
  2. Provide a discrete personal alert (vibration).
  3. Allow for wireless connectivity for those requiring carer / nursing support.
  4. Allow for differences in patient dexterity; two distinct probe systems (microbutton or microwire sensor) will be validated.

Therefore, this study seeks to test the sensor technology with ileostomates in a cross over study involving microbutton and microwire sensors. This study hopes to achieve an 85% success rate in the accurate detection of leaks.

The secondary aim of this study is to determine associations between dietary intake and the incidence of leakages. This information will have the potential to inform the development of dietary guidelines for those living with a stoma, and to therefore improve overall nutritional status and health of this patient group.

02

Conditions studied

  • Ileostomy - Stoma

Keywords

  • Ileostomy
  • Stoma-pouch leakage
  • peristomal skin
  • dietary intake
  • quality of life
03

In context

Lead sponsor

University of Ulster is the lead sponsor of 94 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Living with an ileostomy
  • ≥1.5-years post-operative
  • Aged 18+ years
  • Experiencing frequent leaks (i.e., more than once per week)
  • Males and females (not currently pregnant/lactating)
  • Self-manging their own stoma
  • Access to computer / mobile device for survey completion
  • No learning or other disabilities
  • Have never used / trialled other leak detection systems

Exclusion criteria

Exclusion Criteria:

  • Never had an ileostomy,
  • Individuals with previous ileostomy or ostomy (colostomy or urostomy)
  • \<1.5-year post-operative
  • \<18 years
  • Do not experience frequent leaks (i.e., less than once per week)
  • Adults with learning or other disabilities
  • Have previously used other leak detection systems
  • Pregnant/lactating female
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Leak detection device (microbutton probes)

    Leakage events will be detected by microbutton probes, which are attached to the sensing device

    Device: Stomasense

  • Experimental
    Leak detection device (microwire probes)

    Leakage events will be detected by microwire probes, which are attached to the sensing device

    Device: Stomasense

Interventions

  • DeviceStomasense

    A smart device worn alongside stoma pouch systems which detects onset of a leak.

06

What researchers measure

Primary outcomes

  1. Psychiatric morbidity

    Psychiatric morbidity will be assessed at the beginning and end of each test period using the General Health Questionnaire (GHQ-12).

    Time frame: Comparison between treatments over a 2-week period.

  2. Psychological well-being

    Psychological well-being will be assessed at the beginning and end of each test period using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

    Time frame: Comparison between treatments over a 2-week period.

  3. General quality of life

    General quality of life will be assessed at the beginning and end of each test period using the European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire for colorectal cancer (EORTCQLQ-CR38).

    Time frame: Comparison between treatments over a 2-week period.

  4. General quality of life

    General quality of life will be assessed at the beginning and end of each test period using the The World Health Organization Quality of Life - BREF (WHOQOL-BREF).

    Time frame: Comparison between treatments over a 2-week period.

  5. Stress and coping

    Stress and coping will be assessed at the beginning and end of each test period using the Perceived Stress Scale (PSS), which is a global measure of stress

    Time frame: Change over 2 weeks comparison between treatments

  6. Resillience

    Resillience will be assessed at the beginning and end of each test period using the Connor-Davidson Resilience Scale (CD-RISC)

    Time frame: Change over 2 weeks comparison between treatments

  7. Stoma related quality of life

    Stoma related quality of life will be assessed at the beginning and end of each test period using the Stoma QoL: A Quality-of-Life Questionnaire for People with an Ostomy

    Time frame: Comparison between treatments over a 2-week period.

Secondary outcomes

  1. Device accuracy

    Participants will keep a daily leak diary in which the incidence of leaks will be recorded. Participants will log leakage events as true positive (TP; successful detection of leak), false positive (FP; sensor alert but no leak occurred) or false negative (FN; occurrence of leak but no alert from device).

    Time frame: Measured over 2 weeks comparison between treatments

  2. Device usability

    Participants will complete a user experience survey at the end of each treatment period.

    Time frame: Measured at 2 weeks comparison between treatments

  3. Dietary intake

    Participants will complete 4-day food diaries at the beginning and end of each treatment period.

    Time frame: Measured over 2 weeks comparison between treatments

  4. Peristomal skin condition

    Participants will complete a short questionnaire which evaluates peristomal skin condition at the beginning and end of each treatment period.

    Time frame: Comparison between treatments over a 2-week period.

07

Study locations

1 site
  • Ulster University, Human Intervention Studies Unit
    Coleraine, Co. Derry BT521SA, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06914804
Lead sponsor
University of Ulster
Responsible party
Sponsor
First posted
Apr 6, 2025
Start date
Apr 14, 2025 (estimated)
Primary completion
Jan 31, 2026 (estimated)
Completion
Jan 31, 2026 (estimated)
Last update
Apr 6, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion